[
  {
    "ts": null,
    "headline": "CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond.",
    "summary": "CVS Health  issued an update to its full-year guidance Tuesday ahead of its annual investor day, pointing to stronger performance in 2025 than previously expected.  CVS now sees total revenue of at least $400 billion, up from $397.3 billion previously and above Wall Street’s forecast for $398.4 billion, according to FactSet.  The owner of the drugstore chain and insurance giant Aetna guided for adjusted earnings in the range of $6.60 to $6.70 a share, compared with a prior range of $6.55 to $6.65.",
    "url": "https://finnhub.io/api/news?id=379065bc105dc47ea32741a46f6dca0ed2366ae41d4965ae537891a494677b07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765283700,
      "headline": "CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond.",
      "id": 137740339,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "CVS Health  issued an update to its full-year guidance Tuesday ahead of its annual investor day, pointing to stronger performance in 2025 than previously expected.  CVS now sees total revenue of at least $400 billion, up from $397.3 billion previously and above Wall Street’s forecast for $398.4 billion, according to FactSet.  The owner of the drugstore chain and insurance giant Aetna guided for adjusted earnings in the range of $6.60 to $6.70 a share, compared with a prior range of $6.55 to $6.65.",
      "url": "https://finnhub.io/api/news?id=379065bc105dc47ea32741a46f6dca0ed2366ae41d4965ae537891a494677b07"
    }
  }
]